Guizhou Xinbang Pharmaceutical (002390.SZ) stated on the investor interaction platform that its hospitals have testing services for lymphocyte subsets, lymphocyte activation, dendritic cells, cell apoptosis, and leukemia immunological analysis.
信邦制药(002390.SZ)：旗下医院有淋巴细胞亚群、淋巴细胞活化、树突状细胞、细胞凋亡及白血病免疫分析等检测业务
Guizhou Xinbang Pharmaceutical (002390.SZ): Its hospital offers testing services such as lymphocyte subgroups, lymphocyte activation, dendritic cells, cell apoptosis, and leukemia immune analysis.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated